TherapeuticsMD, Inc.
TXMD
Last
$2.06
Day
+2.5%
1y
+89.6%
5y
-94.3%
52w
-31.9%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1131d
EMA 21
2.07
EMA 50
2.09
EMA 200
2.00
20d high
-9.0%
5y high
-95.1%
5y range
3th
Positions held
Your positionsTXMD isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-16
Hold
avoid
Signal
Strong Sell
Target
$2.13
Stop
$1.91
Stop distance
7.3%
Target vs last
+3.4%
Fundamentals
| Market cap | $23.26M | Enterprise value | $19.64M | Trailing P/E | — | Forward P/E | 5.74 |
| PEG | — | Price / book | 0.86 | Beta | 0.65 | Dividend yield | 0.00% |
| Revenue growth | -8.7% | Earnings growth | -80.6% | Gross margin | 100.0% | Operating margin | -32.2% |
| Profit margin | -6.6% | ROE | -1.1% | ROA | -2.9% | Debt / equity | 0.20 |
| Current ratio | 3.22 | Free cash flow | $896,625 | Analyst recommendation | none | Mean target | — |
| 52w high | $2.95 | 52w low | $1.03 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | — | $0.7M | $0.9M | $0.8M | $1.0M | $0.4M |
| Op margin | — | -99.9% | -167.5% | -105.9% | -73.0% | -303.6% |
| Net income | — | $0.1M | -$0.6M | $0.2M | $0.6M | -$0.7M |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | -$0.7M | -$1.5M | -$0.8M | -$0.7M | -$1.2M |
- Revenue -19% vs prior quarter ($0.7M vs $0.9M).
- Operating margin expanded to -99.9%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.0M | $1.8M | $1.3M | $70.0M | — |
| Op margin | -139.4% | -275.1% | -654.6% | 15.2% | — |
| Net income | -$0.6M | -$2.2M | -$10.3M | $112M | — |
| Gross margin | — | — | 100.0% | 98.0% | — |
| Gross profit | — | — | $1.3M | $68.6M | $1.2M |
| Operating income | -$4.2M | -$4.8M | -$8.5M | $10.7M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-08-11 · TherapeuticsMD: Q2 Earnings Snapshot
2026-08-11 · TherapeuticsMD Announces Second Quarter 2026 Financial Results
Price (daily)
Full chart · RSI · MACD · patternsTXMD · daily-6.9% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin